Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coiffier

Showing results (231-240 of 289) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant RegistryC D Williams, C N Harrison, T A Lister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'AdulteD Decaudin, E Lepage, N Brousse, et al.
Blood|April 1, 1994
Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomasR Rimokh, F Berger, G Delsol, et al.
Cancer Treatment Reports|February 1, 1986
Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemiasD Fière, L Campos, H V Van, et al.
Leukemia & Lymphoma|July 29, 2016
Involvement of the BCL2 Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell CycleP Cornillet, R Rimokh, F Berger, et al.
Leukemia|May 4, 2007
Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell originA Traverse-Glehen, A Verney, L Baseggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphomaF Morschhauser, S Depil, E Jourdan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adultsO Hequet, Q H Le, I Moullet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 2, 2009
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphomaC Haioun, N Mounier, J F Emile, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Primary thyroid lymphoma is a heterogeneous diseaseC Thieblemont, A Mayer, C Dumontet, et al.
Pageof 29

Showing results (231-240 of 289) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant RegistryC D Williams, C N Harrison, T A Lister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'AdulteD Decaudin, E Lepage, N Brousse, et al.
Blood|April 1, 1994
Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomasR Rimokh, F Berger, G Delsol, et al.
Cancer Treatment Reports|February 1, 1986
Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemiasD Fière, L Campos, H V Van, et al.
Leukemia & Lymphoma|July 29, 2016
Involvement of the BCL2 Gene in 131 Cases of Non-Hodgkin's B Lymphomas: Analysis of Correlations with Immunological Findings and Cell CycleP Cornillet, R Rimokh, F Berger, et al.
Leukemia|May 4, 2007
Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell originA Traverse-Glehen, A Verney, L Baseggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphomaF Morschhauser, S Depil, E Jourdan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adultsO Hequet, Q H Le, I Moullet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 2, 2009
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphomaC Haioun, N Mounier, J F Emile, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Primary thyroid lymphoma is a heterogeneous diseaseC Thieblemont, A Mayer, C Dumontet, et al.
Pageof 29